A detailed history of Alapocas Investment Partners, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Alapocas Investment Partners, Inc. holds 26,346 shares of DHR stock, worth $6.09 Million. This represents 4.3% of its overall portfolio holdings.

Number of Shares
26,346
Previous 26,358 0.05%
Holding current value
$6.09 Million
Previous $6.59 Million 11.21%
% of portfolio
4.3%
Previous 3.91%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $2,871 - $3,369
-12 Reduced 0.05%
26,346 $7.32 Million
Q2 2024

Aug 09, 2024

BUY
$235.51 - $267.98 $88,551 - $100,760
376 Added 1.45%
26,358 $6.59 Million
Q1 2024

May 08, 2024

BUY
$224.58 - $256.19 $81,297 - $92,740
362 Added 1.41%
25,982 $6.49 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $44,979 - $56,650
243 Added 0.96%
25,620 $5.93 Million
Q3 2023

Nov 06, 2023

BUY
$233.08 - $265.59 $138,216 - $157,494
593 Added 2.39%
25,377 $6.3 Million
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $33,073 - $37,652
147 Added 0.6%
24,784 $5.95 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $57,060 - $65,926
238 Added 0.98%
24,637 $6.21 Million
Q4 2022

Feb 10, 2023

BUY
$241.42 - $282.29 $101,637 - $118,844
421 Added 1.76%
24,399 $6.48 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $96,353 - $587,886
390 Added 1.65%
23,978 $6.19 Million
Q2 2022

Aug 08, 2022

BUY
$237.11 - $299.66 $228,811 - $289,171
965 Added 4.27%
23,588 $5.98 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $293,287 - $359,966
1,140 Added 5.31%
22,623 $6.64 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $6.27 Million - $7.07 Million
21,483 New
21,483 $7.07 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Alapocas Investment Partners, Inc. Portfolio

Follow Alapocas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alapocas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alapocas Investment Partners, Inc. with notifications on news.